Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical n2 non-small cell lung cancer

HIGHLIGHTS

• who: Luca Bertolaccini from the Shanghai Jiao Tong University School of Medicine, China have published the research work: Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer, in the Journal: (JOURNAL)

SUMMARY

This work aimed to evaluate the long-term clinical outcomes and the prognostic factors of upfront surgery as first-line therapy in biopsy-proven N2 disease. Patients with occult or unforeseen N2 disease do not show lymph node involvement at preoperative staging (clinical N0, cN0 . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.